Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
http://jco.ascopubs.org/cgi/reprint/JCO.2008.19.7681v2
Phase 0 Clinical Trials: An Answer to Drug Development Stagnation?
http://jco.ascopubs.org/cgi/reprint/JCO.2008.21.5798v1
0 件のコメント:
コメントを投稿